申请人:MONSANTO COMPANY
公开号:EP0424349A1
公开(公告)日:1991-04-24
Swainsonine and analogs, namely, 1,4-dideoxy-1,4-imino-D-mannitol and the novel ring contracted swainsonines, (1S,2R,7R,7aR)-1,2-trihydroxypyrrolizidine and (1SD,2R,7S,7aR)-1,2,-7-trihydroxypyrrolizidine, are synthesized from the divergent intermediate, 4,5-anhydro-1-azido-1-deoxy-2,3-O-isopropylidene-D-talitol. These novel compounds are glycosidase inhibitors.
Swainsonine及其类似物,即1,4-二脱氧-1,4-亚胺-D-甘露醇和新型环收缩的Swainsonine,(1S,2R,7R,7aR)-1,2-三羟基吡咯烷和(1SD,2R,7S,7aR)-1,2,-7-三羟基吡咯烷,均由分支中间体4,5-脱水-1-叠氮-1-脱氧-2,3-O-异丙基-D-甘露醇合成。这些新化合物是糖苷酶抑制剂。